‘Biogenerics’: the off-patent biotech products

This publication has 12 references indexed in Scilit:

• Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation
  Biotechnology & Bioengineering, 2000
• Instability, stabilization, and formulation of liquid protein pharmaceuticals
  International Journal of Pharmaceutics, 1999
• Solid‐state chemical stability of proteins and peptides
  Journal of Pharmaceutical Sciences, 1999
• Degradation Products of Factor VIII Which Can Lead to Increased Immunogenicity
  Published by Wiley ,1999
• Epoetin alpha and beta in their erythropoetin isoform compositions and biological properties
  British Journal of Haematology, 1998
• Structural and Functional Differences Between Glycosylated and Non-glycosylated Forms of Human Interferon-β (IFN-β)
  Pharmaceutical Research, 1998
• Getting the glycosylation right: Implications for the biotechnology industry
  Nature Biotechnology, 1996
• Upstream Strategies to Minimize Proteolytic Degradation upon Recombinant Production inEscherichia coli
  Protein Expression and Purification, 1996
• An Enzyme-Linked Immunosorbent Assay (ELISA) for Quantitation of Adducts of Granulocyte–Macrophage Colony Stimulating Factor (GM-CSF) and Human Serum Albumin (HSA) in Stressed Solution Mixtures
  Pharmaceutical Research, 1994
• Deamidation: a source of microheterogeneity in pharmaceutical proteins
  Trends in Biotechnology, 1992